Nature Communications
- Health
Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59
Incheon, South Korea: CT-P59 (40mg/kg) treated patients reported reduced progression rates to severe COVID-19 by 54% for patients with mild-to-moderate…
Read More » - Ministry of Science & Technology
Research by scientists of JNCASR opens up prospects of bio-inspired materials for energy & biotechnology sector
Scientists have developed a synthetic material that mimics the dynamic capability of living organisms to adapt to new environments by…
Read More »